Literature DB >> 34463536

Changes in the Daily Phonotrauma Index Following the Use of Voice Therapy as the Sole Treatment for Phonotraumatic Vocal Hyperfunction in Females.

Jarrad H Van Stan1,2,3, Andrew J Ortiz1, Katherine L Marks1,3, Laura E Toles1,3, Daryush D Mehta1,2,3, James A Burns1,2, Tiffiny Hron1,2, Tara Stadelman-Cohen1,3, Carol Krusemark1,3, Jason Muise1,3, Annie B Fox3, Charles Nudelman1,3, Steven Zeitels1,2, Robert E Hillman1,2,3.   

Abstract

Purpose The aim of this study was to use the Daily Phonotrauma Index (DPI) to quantify group-based changes in the daily voice use of patients with phonotraumatic vocal hyperfunction (PVH) after receiving voice therapy as the sole treatment. This is part of an ongoing effort to validate an updated theoretical framework for PVH. Method A custom-designed ambulatory voice monitor was used to collect 1 week of pre- and posttreatment data from 52 female patients with PVH. Normative weeklong data were also obtained from 52 matched controls. Each week was represented by the DPI, which is a combination of neck-surface acceleration magnitude skewness and the standard deviation of the difference between the first and second harmonic magnitudes. Results Compared to pretreatment, the DPI statistically decreased towards normal in the patient group after treatment (Cohen's d = -0.25). The posttreatment patient group's DPI was still significantly higher than the control group (d = 0.68). Conclusions The DPI showed the pattern of improved ambulatory voice use in a group of patients with PVH following voice therapy that was predicted by the updated theoretical framework. Per the prediction, voice therapy was associated with a decreased potential for phonotrauma in daily voice use, but the posttreatment patient group data were still significantly different from the normative control group data. This posttreatment difference is interpreted as reflecting the impact on voice use of the persistence of phonotrauma-induced structural changes to the vocal folds. Further validation of the DPI is needed to better understand its potential clinical use.

Entities:  

Mesh:

Year:  2021        PMID: 34463536      PMCID: PMC8642084          DOI: 10.1044/2021_JSLHR-21-00082

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  56 in total

1.  Efficacy of a behaviorally based voice therapy protocol for vocal nodules.

Authors:  E B Holmberg; R E Hillman; B Hammarberg; M Södersten; P Doyle
Journal:  J Voice       Date:  2001-09       Impact factor: 2.009

2.  Voice therapy outcomes in vocal fold nodules: a retrospective audit.

Authors:  E McCrory
Journal:  Int J Lang Commun Disord       Date:  2001       Impact factor: 3.020

3.  Differences in temporal variables between voice therapy completers and dropouts.

Authors:  Carissa Portone-Maira; Justin C Wise; Michael M Johns; Edie R Hapner
Journal:  J Voice       Date:  2010-03-17       Impact factor: 2.009

4.  Analysis, synthesis, and perception of voice quality variations among female and male talkers.

Authors:  D H Klatt; L C Klatt
Journal:  J Acoust Soc Am       Date:  1990-02       Impact factor: 1.840

Review 5.  The etiology of vocal fold nodules in adults.

Authors:  Petros D Karkos; Maxwell McCormick
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-12       Impact factor: 2.064

6.  Perceptions of voice therapy from patients diagnosed with primary muscle tension dysphonia and benign mid-membranous vocal fold lesions.

Authors:  Aaron Ziegler; Christina Dastolfo; Rita Hersan; Clark A Rosen; Jackie Gartner-Schmidt
Journal:  J Voice       Date:  2014-05-17       Impact factor: 2.009

7.  Description of laryngeal pathologies by age, sex, and occupation in a treatment-seeking sample.

Authors:  B L Herrington-Hall; L Lee; J C Stemple; K R Niemi; M M McHone
Journal:  J Speech Hear Disord       Date:  1988-02

8.  Recommendations for Reporting on Rehabilitation Interventions.

Authors:  John Whyte; Marcel P Dijkers; Susan E Fasoli; Mary Ferraro; Leanna W Katz; Sarah Norton; Eric Parent; Shanti M Pinto; Sue Ann Sisto; Jarrad H Van Stan; Lauren Wengerd
Journal:  Am J Phys Med Rehabil       Date:  2021-01-01       Impact factor: 2.159

9.  Patient-Reported Factors Associated with the Onset of Hyperfunctional Voice Disorders.

Authors:  Samantha Kridgen; Robert E Hillman; Tara Stadelman-Cohen; Steven Zeitels; James A Burns; Tiffiny Hron; Carol Krusemark; Jason Muise; Jarrad H Van Stan
Journal:  Ann Otol Rhinol Laryngol       Date:  2020-09-10       Impact factor: 1.547

10.  Using Ambulatory Voice Monitoring to Investigate Common Voice Disorders: Research Update.

Authors:  Daryush D Mehta; Jarrad H Van Stan; Matías Zañartu; Marzyeh Ghassemi; John V Guttag; Víctor M Espinoza; Juan P Cortés; Harold A Cheyne; Robert E Hillman
Journal:  Front Bioeng Biotechnol       Date:  2015-10-16
View more
  4 in total

1.  Clinical Cutoff Scores for Acoustic Indices of Vocal Hyperfunction That Combine Relative Fundamental Frequency and Cepstral Peak Prominence.

Authors:  Mara R Kapsner-Smith; Manuel E Díaz-Cádiz; Jennifer M Vojtech; Daniel P Buckley; Daryush D Mehta; Robert E Hillman; Lauren F Tracy; J Pieter Noordzij; Tanya L Eadie; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2022-03-10       Impact factor: 2.674

2.  A Semiautomated Protocol Towards Quantifying Vocal Effort in Relation to Vocal Performance During a Vocal Loading Task.

Authors:  Eric J Hunter; Mark L Berardi; Susanna Whitling
Journal:  J Voice       Date:  2022-02-12       Impact factor: 2.300

3.  Ambulatory Voice Biofeedback: Acquisition and Retention of Modified Daily Voice Use in Patients With Phonotraumatic Vocal Hyperfunction.

Authors:  Jarrad H Van Stan; Andrew J Ortiz; Dagmar Sternad; Daryush D Mehta; Chuanbing Huo; Robert E Hillman
Journal:  Am J Speech Lang Pathol       Date:  2021-11-29       Impact factor: 4.018

4.  Direct measurement and modeling of intraglottal, subglottal, and vocal fold collision pressures during phonation in an individual with a hemilaryngectomy.

Authors:  Daryush D Mehta; James B Kobler; Steven M Zeitels; Matías Zañartu; Emiro J Ibarra; Gabriel A Alzamendi; Rodrigo Manriquez; Byron D Erath; Sean D Peterson; Robert H Petrillo; Robert E Hillman
Journal:  Appl Sci (Basel)       Date:  2021-08-06       Impact factor: 2.838

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.